NASDAQ:ARDS - Aridis Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$11.00 +0.44 (+4.17 %)
(As of 03/20/2019 10:13 AM ET)
Previous Close$10.56
Today's Range$11.00 - $11.00
52-Week Range$7.59 - $13.85
Volume100 shs
Average Volume7,437 shs
Market Capitalization$89.10 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Aridis Pharmaceuticals (NASDAQ:ARDS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Aridis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $28.25, suggesting that the stock has a possible upside of 156.82%. The high price target for ARDS is $40.00 and the low price target for ARDS is $23.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $28.25$28.25$28.25$29.3333
Price Target Upside: 156.82% upside197.37% upside232.74% upside136.79% upside

Aridis Pharmaceuticals (NASDAQ:ARDS) Consensus Price Target History

Price Target History for Aridis Pharmaceuticals (NASDAQ:ARDS)

Aridis Pharmaceuticals (NASDAQ:ARDS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/9/2019Cantor FitzgeraldReiterated RatingBuy$25.00MediumView Rating Details
12/12/2018Maxim GroupSet Price TargetBuy$25.00LowView Rating Details
9/10/2018Northcoast ResearchInitiated CoverageOutperform$40.00LowView Rating Details
9/10/2018Northland SecuritiesInitiated CoverageOutperformLowView Rating Details
9/10/2018LaidlawInitiated CoverageBuy$23.00LowView Rating Details
(Data available from 3/20/2017 forward)
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel